DexCom, Inc.

DXCM

$62.68

Name : DexCom, Inc.

Sector : Healthcare

Industry: Medical Devices

Mark. Cap: $24,446,218,240.00

EPSttm : 2.09

DexCom, Inc.

$62.68

0.70%

$0.44

DXCM — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

3.88

Margin Of Safety %

Put/Call OI Ratio

0.96

EPS Next Q Diff

-0.08

EPS Last/This Y

0.36

EPS This/Next Y

0.5

Price

63.15

Target Price

87.26

Analyst Recom

1.52

Performance Q

-6.35

Upside

15.9%

Beta

1.54

Ticker: DXCM

17 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-17	DXCM	67.31	0.82	0.18	110632
2026-03-18	DXCM	67.65	0.82	0.65	111482
2026-03-19	DXCM	67.27	0.82	0.51	111632
2026-03-20	DXCM	66.83	0.83	0.95	111821
2026-03-23	DXCM	65.94	0.96	0.50	80966
2026-03-24	DXCM	66.55	0.96	0.57	82138
2026-03-25	DXCM	66.82	0.95	2.08	82716
2026-03-26	DXCM	66.09	0.96	0.19	83132
2026-03-27	DXCM	62.13	0.96	0.47	83641
2026-03-30	DXCM	61.96	0.98	0.36	81756
2026-03-31	DXCM	62.8	0.95	0.80	83441
2026-04-01	DXCM	62.36	0.95	0.89	83811
2026-04-02	DXCM	62.21	0.95	0.37	83947
2026-04-06	DXCM	63.12	0.96	0.43	83157
2026-04-08	DXCM	65.85	0.96	0.15	84225
2026-04-09	DXCM	65.67	0.94	2.81	85163
2026-04-13	DXCM	63.15	0.96	0.89	84908
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

17 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-17	DXCM	67.33	48.1	-64.8	2.50
2026-03-18	DXCM	67.62	48.1	-75.7	2.50
2026-03-19	DXCM	67.29	48.1	-170.0	2.50
2026-03-20	DXCM	66.95	48.1	-169.6	2.50
2026-03-23	DXCM	65.94	48.1	-179.2	2.50
2026-03-24	DXCM	66.57	48.1	-155.5	2.50
2026-03-25	DXCM	66.81	48.1	-28.3	2.50
2026-03-26	DXCM	66.11	47.2	-43.7	2.49
2026-03-27	DXCM	62.30	47.2	-94.9	2.49
2026-03-30	DXCM	61.90	47.2	-37.8	2.49
2026-03-31	DXCM	62.80	46.8	-15.7	2.49
2026-04-01	DXCM	62.37	46.8	-39.3	2.49
2026-04-02	DXCM	62.22	46.8	-34.4	2.49
2026-04-06	DXCM	63.22	46.8	-14.0	2.49
2026-04-07	DXCM	63.12	46.8	-33.4	2.49
2026-04-08	DXCM	65.84	47.6	15.8	2.49
2026-04-09	DXCM	65.68	47.2	-34.2	2.49
2026-04-10	DXCM	64.01	47.2	-59.7	2.49
2026-04-13	DXCM	63.15	47.2	-46.8	2.50
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-17	DXCM	0.17	-1.74	4.04
2026-03-18	DXCM	0.14	-1.74	4.04
2026-03-19	DXCM	0.14	-1.74	4.04
2026-03-20	DXCM	0.14	-1.74	4.04
2026-03-23	DXCM	0.14	-2.29	4.04
2026-03-24	DXCM	0.14	-2.29	4.04
2026-03-25	DXCM	0.14	-2.29	4.29
2026-03-26	DXCM	0.14	-2.29	4.29
2026-03-27	DXCM	0.14	-2.29	4.29
2026-03-30	DXCM	0.14	-2.28	4.29
2026-03-31	DXCM	0.14	-2.28	4.29
2026-04-01	DXCM	0.14	-2.28	4.29
2026-04-02	DXCM	0.14	-2.28	4.29
2026-04-06	DXCM	0.14	-2.23	4.29
2026-04-07	DXCM	0.14	-2.23	4.29
2026-04-08	DXCM	0.14	-2.23	4.29
2026-04-09	DXCM	0.14	-2.23	4.29
2026-04-10	DXCM	0.14	-2.23	4.29
2026-04-13	DXCM	0.14	-2.27	3.88
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

0.68

Avg. EPS Est. Current Quarter

0.47

Avg. EPS Est. Next Quarter

0.6

Insider Transactions

0.14

Institutional Transactions

-2.27

Beta

1.54

Average Sales Estimate Current Quarter

1174

Average Sales Estimate Next Quarter

1297

Fair Value

66.96

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

61.7

Max Drawdown 5-Year %

-66.3

Target Price

87.26

P/E

30.16

Forward P/E

21.1

PEG

1.07

P/S

5.21

P/B

8.85

P/Free Cash Flow

22.55

EPS

2.09

Average EPS Est. Cur. Y

2.5

EPS Next Y. (Est.)

2.99

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

17.94

Relative Volume

1.17

Return on Equity vs Sector %

3.1

Return on Equity vs Industry %

18.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-46.8

◆ DXCM Healthcare

$63.12

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

22/25

Volume

4/15

Valuation

18/20

TP/AR

1/10

Options

1/10

RSI

40.2

Range 1M

18.8%

Sup Dist

0.1%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

14/25

Growth

19/30

Estimates

6/20

Inst/Vol

2/15

Options

3/10

EPS Yr

19%

EPS NY

20.3%

52W%

22.3%

💎

Long-Term Value

Quality companies, undervalued

WATCH

🟢 BUY +42.4% upside

Quality

30/30

Valuation

18/30

Growth

16/25

Stability

6/10

LT Trend

4/5

Upside

+42.4%

Quality

MoS

DexCom, Inc.

Sector: Healthcare

Industry: Medical Devices

Employees: 11000

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DXCM

Latest News

—

Caricamento notizie per DXCM…

stock quote shares DXCM – DexCom, Inc. Stock Price stock today

news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DXCM – DexCom, Inc. yahoo finance google finance

stock history DXCM – DexCom, Inc. invest stock market

stock prices DXCM premarket after hours

ticker DXCM fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: DXCM

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y